Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 1Enrolling by invitation 1Completed 1

Sponsor Class

INDUSTRY 2OTHER 1

Study Type

Observational 2Interventional 1

Sponsor

Cancer Type

Endocrine 1

Conditions

Neuromuscular Manifestations 2Neuromuscular Diseases 2Myasthenia Gravis 2Multiple Endocrine Neoplasia Type 1 1

Interventions

Cisplatin 3202Cyclophosphamide 3195Carboplatin 2977Radiotherapy 2790Paclitaxel 2718Gemcitabine 2572pembrolizumab 2385Bevacizumab 2209Docetaxel 2199Fluorouracil 1851Capecitabine 1833Oxaliplatin 1742Dexamethasone 1605Nivolumab 1581Doxorubicin 1501Rituximab 1488Magnetic Resonance Spectroscopy 1387Etoposide 1346Irinotecan 1248Leucovorin 1226Drug Therapy 1205Cytarabine 1130Pemetrexed 1076fludarabine 1063Specimen Handling 1017Vincristine 964Cetuximab 945Trastuzumab 945Prednisone 942Lenalidomide 937

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Diagnostic Self Evaluation × Clear all
NCT06954909 2026-05-08

The Impact of Self-assessment on Hydration

Arizona State University

Phase NA Enrolling by invitation
38 enrolled
Endocrine

Multiple Endocrine Neoplasia Type 1

NCT06381284 2025-03-25

Expediting Myasthenia Gravis (MG) Diagnostic Evaluation: A Novel, Proof-of-Concept for Undiagnosed, Symptomatic Patients That Uses Social Media Targeting and Self-Assessment

ZS Associates

Completed
215 enrolled

Myasthenia Gravis, Neuromuscular Diseases, Neuromuscular Manifestations

NCT06866483 2025-03-10

Validation and Scaling of Screening Program for Undiagnosed Myasthenia Gravis-Social Media Campaign Paired With a Self-moderated Assessment

ZS Associates

Recruiting
1,000 enrolled

Myasthenia Gravis, Neuromuscular Diseases, Neuromuscular Manifestations

Data powered by HemOnc (CC BY 4.0) Colophon âš¡